Sowell Financial Services LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,004 shares of the financial services provider's stock, valued at approximately $977,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Norges Bank purchased a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $1,236,186,000. Stifel Financial Corp lifted its stake in Marsh & McLennan Companies by 551.0% in the fourth quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider's stock worth $472,599,000 after acquiring an additional 1,883,146 shares during the last quarter. Amundi lifted its stake in Marsh & McLennan Companies by 81.1% in the fourth quarter. Amundi now owns 4,072,976 shares of the financial services provider's stock worth $860,824,000 after acquiring an additional 1,823,807 shares during the last quarter. GAMMA Investing LLC raised its holdings in Marsh & McLennan Companies by 32,120.9% during the first quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider's stock worth $369,869,000 after purchasing an additional 1,510,966 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Marsh & McLennan Companies during the fourth quarter worth approximately $207,278,000. Hedge funds and other institutional investors own 87.99% of the company's stock.
Insider Buying and Selling at Marsh & McLennan Companies
In related news, SVP Paul Beswick sold 2,237 shares of the business's stock in a transaction on Thursday, April 3rd. The stock was sold at an average price of $246.00, for a total value of $550,302.00. Following the sale, the senior vice president now owns 13,522 shares of the company's stock, valued at $3,326,412. The trade was a 14.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Dean Michael Klisura sold 9,569 shares of the business's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $245.00, for a total value of $2,344,405.00. Following the sale, the chief executive officer now owns 20,935 shares of the company's stock, valued at approximately $5,129,075. The trade was a 31.37% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.35% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on MMC shares. Wells Fargo & Company lifted their target price on shares of Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. UBS Group boosted their target price on shares of Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a "buy" rating in a research report on Wednesday, April 9th. Keefe, Bruyette & Woods decreased their target price on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating on the stock in a research report on Monday, April 21st. Jefferies Financial Group boosted their target price on shares of Marsh & McLennan Companies from $237.00 to $244.00 and gave the stock a "hold" rating in a research report on Friday, April 11th. Finally, Redburn Atlantic began coverage on shares of Marsh & McLennan Companies in a research report on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price objective on the stock. Two analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average target price of $241.93.
View Our Latest Research Report on MMC
Marsh & McLennan Companies Stock Down 0.8%
MMC opened at $214.22 on Thursday. Marsh & McLennan Companies, Inc. has a fifty-two week low of $207.21 and a fifty-two week high of $248.00. The business has a 50-day moving average of $225.76 and a 200-day moving average of $225.03. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.14 and a quick ratio of 1.14. The company has a market capitalization of $105.55 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 2.65 and a beta of 0.83.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, topping analysts' consensus estimates of $3.02 by $0.04. Marsh & McLennan Companies had a return on equity of 32.19% and a net margin of 16.13%. The company had revenue of $6.70 billion during the quarter, compared to the consensus estimate of $7.08 billion. During the same period last year, the business earned $2.89 EPS. Equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.
Marsh & McLennan Companies Company Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Read More
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.